| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Zoghbi Huda Y serves as a Director at REGN. Across recent SEC filings that breaks down to 0 buys and 34 sells. Those positions are worth an estimated $1.4M at current prices.
Historically, Zoghbi Huda Y's trades have earned a below-average insider score of 39/100 across 5 rated trades. Over a 12-month horizon, 20.0% of those trades were profitable, with an average 12-month return of -5.7%.
The biggest single holding is REGN (~$1.4M) as Director. The recent filings there lean toward selling, a net 17,791 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10, 2026 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 800 | $800.00 | $640,000.00 | -32.0% | - | - | |
| Feb 19, 2026 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 1,638 | $781.33 | $1,279,811.86 | -49.0% | -17.0% | - | |
| Jan 2, 2024 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 1,117 | $900.00 | $1,005,300.00 | -47.3% | +7.1% | -21.0% | |
| Oct 13, 2023 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE10b5-1 | 1,000 | $850.00 | $850,000.00 | -44.5% | +9.1% | +21.0% | |
| Mar 16, 2022 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 2,000 | $675.00 | $1,350,000.00 | -64.9% | -19.1% | +10.6% | |
| Sep 14, 2021 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 1,000 | $650.00 | $650,002.20 | -52.9% | +2.3% | +8.1% | |
| Jul 7, 2020 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 1,706 | $650.00 | $1,108,900.00 | -72.6% | - | - | |
| Jun 11, 2020 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 3,412 | $617.62 | $2,107,318.30 | -84.1% | - | - | |
| May 7, 2020 | REGN Regeneron Pharmaceuticals, Inc. | Director | Sale+OE | 5,118 | $566.52 | $2,899,461.05 | -88.8% | - | - |